key: cord-0710564-37ziezbl
authors: Malkov, Egor
title: Simulation of Coronavirus Disease 2019 (COVID-19) Scenarios with Possibility of Reinfection
date: 2020-09-18
journal: Chaos Solitons Fractals
DOI: 10.1016/j.chaos.2020.110296
sha: 64a30d75cb0d0c7389c11c2f73dbbdc5ccfa464c
doc_id: 710564
cord_uid: 37ziezbl

Epidemiological models of COVID-19 transmission assume that recovered individuals have a fully protected immunity. To date, there is no definite answer about whether people who recover from COVID-19 can be reinfected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the absence of a clear answer about the risk of reinfection, it is instructive to consider the possible scenarios. To study the epidemiological dynamics with the possibility of reinfection, I use a Susceptible-Exposed-Infectious-Resistant-Susceptible model with the time-varying transmission rate. I consider three different ways of modeling reinfection. The crucial feature of this study is that I explore both the difference between the reinfection and no-reinfection scenarios and how the mitigation measures affect this difference. The principal results are the following. First, the dynamics of reinfection and no-reinfection scenarios are indistinguishable before the infection peak. Second, the mitigation measures delay not only the infection peak, but also the moment when the difference between the reinfection and no-reinfection scenarios becomes prominent. These results are robust to various modeling assumptions.

The rapid spread of coronavirus disease 2019 (COVID-19) creates significant challenges for economies and healthcare systems of many countries around the world. The situation evolves extremely quickly and, to date, there is a high degree of uncertainty about the future outcomes of the pandemic. As of September 1, 2020, there have been 25.9 million confirmed cases globally, including about 860 thousand deaths, see Worldometers (2020) .

One of the crucial questions that still has no definite answer is whether people who recover from COVID-19 can be reinfected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The case reports are scarce -there are a few of them about positive testing after recovering from COVID-19 in China, Japan, and South Korea -and it is not clear whether these patients are truly reinfected or not. Shi et al. (2020) discuss the immune responses induced by COVID-19. Another study, Bao et al. (2020) , using the sample of four rhesus macaques, conclude that the primary SARS-CoV-2 infection could protect from subsequent reinfections. In turn, An et al. (2020) , show that 38 out of 262 patients, i.e. 14.5 percent, recovered from COVID-19, tested positive for SARS-CoV-2, using polymerase chain reaction (PCR) tests, after being discharged from the hospital in Shenzhen. Those patients did not show obviously clinical symptoms and disease progression upon readmission.

A recent study by To et al. (2020) shows the results of the whole genome sequencing that was performed directly on respiratory specimens collected during two episodes of COVID-19 in a patient. Epidemiological, clinical, serological, and genomic analyses confirmed that the patient had reinfection instead of persistent viral shedding from first infection. Their paper suggests that SARS-CoV-2 may continue to circulate among the human populations despite 2 herd immunity due to natural infection or vaccination.

In the absence of a clear answer about the risk of reinfection with the new coronavirus, it is instructive to be aware of the possible scenarios. This study aims at providing the attempt in this direction. I use a Susceptible-Exposed-Infectious-Resistant-Susceptible (SEIRS) model that differs from a standard SEIR model, considered in Hethcote (2000) and Chowell et al. (2004) , and, in application to COVID-19, Kucharski et al. (2020) , Lin et al. (2020 ), Prem et al. (2020 , and Wang et al. (2020) , with an additional assumption that recovered individuals can become susceptible to infection again. In methodologically related papers, Reynolds et al. (2014) and Etbaigha et al. (2018) study the reinfection of swines with influenza A virus (IAV). The simulations considered in this paper are by no means the definitive quantitative forecasts. Instead, the purpose is to show the patterns of the disease dynamics if people can be reinfected with the new coronavirus. In fact, the risk of reinfection would definitely affect the scope and duration of policies that are currently in place.

I consider three different ways of modeling reinfection. I begin with the model where individuals have constant immunity waning rate and study the effects of the mitigation policies captured by the time-varying transmission rate and hence the reproduction number.

The basic reproduction number, R 0 , is a crucial parameter for evaluation the spread of the infection and the effects of mitigation measures. Existing estimates for COVID-19 suggest that R 0 is between 2 and 4. Using the data from Wuhan, China, Wu et al. (2020) estimate R 0 to be 2.68 (95% confidence interval (CI): 2.47-2.86). Using the data from mainland China, Zhao et al. (2020) conclude that the mean estimate of R 0 ranges from 2.24 (95% CI: 1.96-2.55) to 3.58 (95% CI: 2.89-4.39). Using the data for Italy, Remuzzi and Remuzzi (2020) propose R 0 to be in the range 2.76-3.25. Using the data for Japan, Kuniya (2020) estimate 3 R 0 to be 2.6 (95% CI: 2.4-2.8). Fauci et al. (2020) propose R 0 to be 2.2. Sanche et al. (2020) obtain a higher median estimate, R 0 = 5.7 (95% CI: 3.8-8.9). Beyond that, Korolev (2020) shows that estimates of R 0 are highly sensitive to the values of epidemiologic parameters. In the simulations, I consider the range of values of the basic reproduction number.

Crucially, in each model experiment I consider not only how different are the reinfection and no-reinfection scenarios, but also how the mitigation measures affect this difference. To check the robustness of my findings about the role of the mitigation measures with and without reinfection, I turn to the alternative modeling assumptions about reinfection. The conceptual framework that I use can be easily incorporated into more complex models in future studies.

Consider a SEIRS model with constant population N normalized to one. Each period of time, the population consists of four classes: susceptible (S), exposed (E), infected (I), and resistant (recovered or dead) (R):

Since N = 1, variables S, E, I, and R correspond to the fractions of the population. I assume that recovered individuals can become susceptible to infection again at rate ω. The compartmental model is formulated by the following set of ordinary differential equations:

The transmission rate, β(t), accounts for the rate at which infected individuals interact with others and transmit the disease and is given by

whereR ( 

whereR 1 (0) andR 2 (0) (R * 1 and R * 2 ) are the initial (long-run) values forR 1 andR 2 . Parameter η 1 determines the rate at whichR 1 converges to R * 1 . In turn, parameter η 2 governs the rate at whichR 2 converges to R * 2 . By appropriately choosing the parameter values, I can capture different scenarios of the mitigation policies. In particular, in the simulations in Section 3, I vary the speed of imposing the mitigation measures and also consider the scenario when extremely severe mitigation measures at the beginning of the pandemic are followed by their gradual relaxation. From (7)-(9), the dynamics ofR 1 ,R 2 , andR is described by the following equations:

Parameters (σ, γ, ω) represent the characteristics of COVID-19 and assumed to be constant. For parameters σ and γ, I take the estimates from the literature. The parameter σ stands for the mean incubation period of the disease, and its estimates vary from 1/5.2 to 1/3, see Lin et al. (2020) and Wang et al. (2020) . Following Li et al. (2020a) and Wang et al.

(2020), I adopt a mean latent period of 5.2 days (infection rate, σ = 1/5.2). Next, I adopt a mean infectious period of 18 days (recovery rate, γ = 1/18) in line with Chen et al. (2020) and Wang et al. (2020) . Parameter ω, the immunity waning rate, is of the main interest for this paper, and since, to date, there are no credible estimates of it, I consider the range of different values, ω ∈ {0, 1/365, 1/183, 1/120, 1/60}. To et al. (2020) show that the second episode of asymptomatic infection occurred 142 days after the first symptomatic episode in an apparently immunocompetent patient. This period is consistent with considered range 6 of ω. The case ω = 0 corresponds to no reinfection. The value of ω is driven by immunity waning after the infection or the rate of virus mutation. Next, the initial values for actively infected and exposed population are taken for the United States and set to I ( 

In this section, I use the assumptions about the time paths forR from Atkeson (2020) .

This allows me to clearly compare the outcomes under reinfection with his conclusions from the simulations without reinfection. In the first model experiment, I assume thatR is fixed over time. This reflects the scenarios when mitigation efforts do not change over time. with and without reinfection. Second, under the reinfection scenario, the size of the peak is greater than without reinfection. The difference in the peak values is decreasing in R 0 and increasing in the immunity waning rate, ω. Third, with reinfection, the fraction of the actively infected population exhibits asymmetric dynamics around the peak. Crucially, before the peak, the time paths with and without reinfection are indistinguishable. However, after the peak, the reinfection series is unambiguously above the no-reinfection series. Therefore, by reducing the transmission rate with the mitigation measures, we delay the infection peak, and hence delay the moment when the difference between the reinfection and no-reinfection scenarios becomes sizeable. Finally, notice that, with reinfection, there can be multiple-wave disease outbreaks. In a related study, Camacho and Cazelles (2013) discuss the role of homologous reinfection in driving multiple-wave influenza outbreaks. Next, Figure 1e is close to one. This phase diagram also illustrates that before the peak two scenarioswith and without reinfection -are almost indistinguishable.

In the second model experiment, I assume thatR gradually decreases at different speed.

To capture the scenarious under different speed of implementation, following Atkeson (2020), I setR 1 (0) =R 2 (0) = 3, R * 1 = R * 2 = 1.6, and vary parameters η 1 and η 2 with η 1 = η 2 ≡ η.

There are five scenarios: very fast (η = 1/5), fast (η = 1/10), moderate (η = 1/20), slow (η = 1/50), and very slow (η = 1/100). Higher values of η govern higher rate of convergence ofR to the long-run value of 1.6. Figure In the third model experiment, I assume thatR significantly drops at the beginning, as a result of extremely severe mitigation measures, and then gradually goes up, as the mitigation measures are relaxed. Following Atkeson (2020), I setR 1 (0) = 10,R 2 (0) = −4, R * 1 = −10, R * 2 = 4, η 1 = 1/35, and η 2 = 1/100. Given the initial and long-run values of the reproduction number and η 1 > η 2 ,R 1 (t) is rapidly decreasing function whileR 2 (t) is slowly increasing function. As a result, the time path forR(t) has a U-shaped form, see Figure 3a . The other two panels of Figure 3 show the simulated fraction of the actively infected population with and without reinfection. Under the temporary and extremely severe mitigation measures, in the first four months, as shown in Figure 3b , the fraction of the actively infected population substantially goes down. Moreover, the dynamics is identical for the scenarios with and without the possibility of reinfection. Turning to the first 15 months of the pandemic, shown in Figure 3c , we see that gradual relaxation that follows the initial extremely severe mitigation measures, leads to a subsequent peak. Therefore, relaxation of the mitigation measures, driven by the optimistic dynamics in the first months, eventually leads to the epidemic. Motivated by the observation that early mitigation measures delay the peak but not its size, because the population does not acquire herd immunity, Toda (2020) studies the optimal mitigation policy. He shows that it is optimal to initiate the mitigation measures once the number of cases reaches some threshold fraction of the population. 

I consider two alternative ways of modeling reinfection. First, I assume that individuals, once being reinfected, have milder form of the disease. This is in line with An et al. (2020) who discuss the clinical characteristics of the recovered COVID-19 patients with redetectable positive RNA test. When readmitted to the hospital, these patients showed no obvious clinical symptoms or disease progression. In the model, I assume that the individuals who become susceptible after being recovered, have lower transmission rate and higher recovery rate. At each point in time, the population, normalized to one, consists of seven classes: primarysusceptible (S p ), secondary-susceptible (S s ), primary-exposed (E p ), secondary-exposed (E s ), primary-infected (I p ), secondary-infected (I s ), and resistant (recovered or dead) (R):

Individuals belong to S p , E p , or I p if they were not infected before. Individuals belong to S s , E s , or I s after being recovered. The compartmental model is formulated as follows:

Note that susceptible individuals, both those who have never been infected and those who have recovered and are currently susceptible again, become exposed after contacting with both primary-and secondary-infected individuals. In the absence of the parameter estimates for COVID-19, I assume that β s = β p /2, γ s = 2γ p , and σ s = σ p . Following the previous simulations, I set σ p = 1/5.2 and γ p = 1/18. The initial values are I p (0) = 1/1000, and β p = 1/12. The case β p = 1/6 corresponds to R 0 = 3.0 in the baseline SEIRS model from Section 2, while the case β p = 1/12 corresponds to R 0 = 1.5. We can see from Figure 4 that the dynamics of the total fraction of the actively infected population is almost entirely driven by the primary-infected people. There is a limited role of reinfection in the general epidemic dynamics.

Second, instead of a constant immunity waning rate, I assume that the individuals, that are resistant at date t * (those who were infected in the past), become susceptible again. In particular, I consider a standard SEIR model, i.e. one described by equations (1)-(5) with ω = 0. Before date t * , the dynamics of the model coincides with the no-reinfection case.

At date t * , resistant individuals join the pool of susceptible population. Formally this is described by S(t * ) = S(t * − dt) + R(t * − dt) as dt → 0. Therefore, at date t * the fraction of resistant population drops to zero, while the fraction of susceptible population discretely goes up. To illustrate the patterns that arise under this modeling approach of reinfection, I choose two time thresholds, t * = 120 and t * = 30. Figure 5a , then reinfection leads to a double peak. Second, if the infection peak occurs shortly after t * , as in Figure  5b , then reinfection results in a higher single peak. Notice that the simulated series are consistent with the conclusion from Section 3 that the mitigation measures (lower R 0 ) delay not only the infection peak, but also the moment when the difference between the reinfection and no-reinfection scenarios becomes prominent. 

To date, the immune response, including duration of immunity, to SARS-CoV-2 infection

is not yet understood. Unless it is clearly known that patients with COVID-19 are unlikely to be reinfected, it is instructive to consider the possible scenarios. In this paper, I study how the possibility of reinfection shapes the epidemiological dynamics at the population level. To explore the difference in the dynamics of the disease under the reinfection and no-reinfection scenarios and, furthermore, the effects of the mitigation measures, I use a SEIRS model and consider three different ways of modeling reinfection. A key finding is that the mitigation measures delay not only the infection peak, but also the moment when the difference between the reinfection and no-reinfection scenarios becomes prominent. This result is robust to various modeling assumptions. The framework is simple and therefore can serve as a baseline for more complex models.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Clinical Characteristics of the Recovered COVID-19 Patients with Re-Detectable Positive RNA Test

How Will Country-Based Mitigation Measures Influence the Course of the COVID-19 Epidemic?

What Will be the Economic Impact of COVID-19 in the US?

Reinfection Could not Occur in SARS-CoV-2 Infected Rhesus Macaques. bioRxiv

Reopening in an SEIR Model with Testing and Targeted Quarantine

Does Homologous Reinfection Drive Multiple-Wave Influenza Outbreaks? Accounting for

Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study

The Basic Reproductive Number of Ebola and the Effects of Public Health Measures: The Cases of Congo and Uganda

An SEIR Model of Influenza A Virus Infection and Reinfection within a Farrow-to-Finish Swine Farm

Covid-19 -Navigating the Uncharted

The Mathematics of Infectious Diseases

Estimating the Fraction of Unreported Infections in Epidemics with a Known Epicenter: An Application to COVID-19

Identification and Estimation of the SEIRD Epidemic Model for COVID-19

Early Dynamics of Transmission and Control of COVID-19: A Mathematical Modelling Study. The Lancet Infectious Diseases

Prediction of the Epidemic Peak of Coronavirus Disease in Japan

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Substantial Undocumented Infection Facilitates the Rapid Dissemination of Novel Coronavirus (SARS-CoV2)

A Conceptual Model for the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan, China with Individual Reaction and Governmental Action

Outbreak Dynamics of COVID-19 in China and the United States

The effect of control strategies to reduce social mixing on outcomes of the covid-19 epidemic in wuhan, China: A modelling study

COVID-19 and Italy: What Next? The Lancet

Mathematical Modeling of Influenza A Virus Dynamics within Swine Farms and the Effects of Vaccination

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

COVID-19 Infection: The Perspectives on Immune Responses

COVID-19 Re-Infection by a Phylogenetically Distinct SARS-Coronavirus-2 Strain Confirmed by Whole Genome Sequencing

Susceptible-Infected-Recovered (SIR) Dynamics of COVID-19 and Economic Impact

Phase-Adjusted Estimation of the Number of Coronavirus Disease

Coronavirus Cases

Nowcasting and Forecasting the Potential Domestic and International Spread of the 2019-nCoV Outbreak Originating in Wuhan, China: A Modelling Study

Preliminary Estimation of the Basic Reproduction Number of Novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A Data-Driven Analysis in the Early Phase of the Outbreak

I thank the editor, Gabriel B. Mindlin, and two anonymous referees for their constructive comments, which helped me to improve the manuscript. I thank Polina Protasova, James Stock, and Alexis Akira Toda for useful comments and discussion. All remaining errors are mine. The views expressed herein are those of the author and not necessarily those of the Federal Reserve Bank of Minneapolis or the Federal Reserve System.

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Egor Malkov: a single author. redit Author Statement